✦ LIBER ✦

Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas–kidney transplant recipients

✍ Scribed by F. López-Medrano; B. Rueda; M. Lizasoain; R. San Juan; D. Folgueira; A. Andrés; J. M. Morales; C. Jiménez; J. C. Meneu; J. M. Aguado

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preemptive Therapy With Intravenous Ganc

✍ V. Monforte; A. Román; J. Gavaldà; C. Bravo; P. Gispert; A. Pahissa; F. Morell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Preemptive Therapy for the Prevention of

✍ N. Paudice; A. Mehmetaj; M. Zanazzi; L. Moscarelli; R. Piperno; L. Di Maria; E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Preemptive antiviral therapy is highly e

✍ B Radovancevic; C.D Thomas; R Radovancevic; E.L Ford; O.H Frazier 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Preemptive Therapy in the Prevention of

✍ Casquero, S.; Rangel, D.; Lage, E.; Sobrino, M.; Cristobo, P.; Cordero, E.; Cisn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Efficacy and Safety of Valgancyclovir as

✍ C. Dı́az-Pedroche; C. Lumbreras; P. Del Valle; R. San Juan; S. Hernando; D. Folg 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Role of CMV antigenemia directed preempt

✍ S Husain; K.R McCurry; J.H Dauber; R Zomak; P Williams; S Kusne 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB